Europaem.de

Consultation Response Form SCENIHR preliminary report on “The safety of dental amalgam and alternative dental restoration
materials for patients and users”
References / Literature
Case number:
517159724081705308
Due to rare space on the online form we send our literature references in
addition to our consultation response.

Literature
European Academy for Environmental Medicine 1. Adams et al. Mercury, lead, and zinc in baby teeth of children with autism Ask et al. Inorganic mercury and methylmercury in placentas of Swedish 3. Ask K et al. (2002) Inorganic Mercury an Methylmercury in Placentas of Swedish Women, Enviromental Health Perspectives, 110 (5), 523 – 526.
4. Baasch E (1964), Theoretische Überlegungen zur Ätiologie der Sclerosis multiplex, Archiv für Neurologie, Neurochirurgie und Psychiatrie 98, 1 – 19.
5. Bagenstose LM et al. (1998) IL-12 Down-Regulates Autoantibody Production in Mercury-Induced Autoimmunity, J Immunol, 160, 1 – 16.
6. Barregard L et al. (2007) Renal Effects of Dental Amalgam in Children: the New England Childrenûs Amalgan Trial, Environ Health Perspect 10504 online 23 Nov. 2007, 1 – 5.
7. Bartram et al. (2006) Die Bedeutung von Epikutantestungen und Lymphozytentransformationstest für die Diagnostik von Typ IV-Sensibilisierungen. Stellungnahme des Deutschen Berufsverbandes der Umweltmediziner. J Lab Med, 30(2), 101-106.
8. Berlin M. Mercury in dental-filling materials – an updated risk analysis in environmental medical terms. An overview of scientific literature published in 1997-2002 and current knowledge. 2003.
9. Bigazzi PE (1999) Gold-Induced Renal Autoimmunity, Mercury-Induced Renal Autoimmunity, Conclusions, Environ Health Perspect, 107 (S5), 1 –33.
10. Bigazzi PE (2008) Metals and Kidney Autoimmunity, ehp Volume 116, Nr. 2: 11. Björnberg et al. Transport of methylmercury and inorganic mercury to the fetus and breast-fed infant. Env. Health Persp 2005 EUROPEAN ACADEMY FOR ENVIRONMENTAL MEDICINE e.V.
- Enrolled in the Register of Societies and Associations – Amtsgericht Würzburg VR 2055
- First Chairman: Dr. Kurt E. Müller – Managing Chairmann: Dr. Peter Ohnsorge
- Public-minded and nonprofit-making objects in accordance with the „Tax Privileged Objects“ of the German tax code.
- Banking-account: 43812841 Sparkasse Mainfranken: BLZ 790 500 00
- IBAN: DE 36 7905 0000 0043 812841 – SWIFT-BIC:BYLADEM1SWU
12. Black RS et al. (1979) Influence of Silver, Mercury, Lead, Cadmium, and Selenium on Glutathione Peroxidase and Transferase Activities in Rats. Mological Trace Elem Res 1, 313-324.
13. Boadi et al. In vitro exposure to mercury and cadmium alters term human placental membrane fluidity. Toxicol Appl Pharm 1992 14. Bradstreet et al. A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders. J Amer Phys and Surg 2003 15. Burrows D (1986) Hypersensitivity to mercury, nickel an chromium in relation to dental materials, Intern Dent J, 36, 30 – 34.
16. Cheuk Wong. Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children. Neuropediatrics 2006 Aug;37(4):234-40 17. Clark R et al. (1972) Statistische Untersuchung zur Frage der Kreuzallergie bei Metallsalzen, ??? Heft 5/1972: 222 – 239.
18. Clarkson TW (2002) The three modern faces of mercury. Environ Health 19. Clarkson TW et al. (1972) The Transport of Elemental Mercury into Fetal Tissues, Bio. Neonate, 21, 239 – 244.
20. Clarkson TW et al. (1985) Reproductive an developmental toxicity of metals, Scand J Work Environ Health, 11, 145 – 154.
21. Counter. Mercury exposure in children:a review. Toxicol Appl Pharm 2004 22. Cox NH et al. (1988) Thiomersal allergy and vaccination reactions, Contact 23. Da Costa et al. Breast-milk mercury concentrations and amalgam surface in mothers from Brasília Biol Trace Elem Res 2005 24. Davis BJ et al. (2001) Mercury Vapor and Female Reproductive Toxicity, Toxicological Sciences 59, 291 – 296.
25. Drasch et al. Mercury in human colostrum and early breast milk. Its dependence on dental amalgam J Trace Elem Med Biol 1998 26. Drasch et al. Mercury burden of human fetal and infant tissues. Eur J Pediatr 27. Drasch G et al. (1997) Einfluß von Amalgamfüllungen auf die Quecksilber- konzentration in menschlichen Organen. Deutsch Zahnärztl Z 47, 490-496.
28. Drasch et al. (1997) Are blood, urine, hair and muscle valid bio.monitoring parameters for the internal burden of men with heavy metals mercury, lead and cadmium? Trace Elem Electrolytes 14, 116-123.
29. Drasch G et al. (2000) The Mt. Diwata study on the Philippines 1999 – assessing mercury intoxication of the population by small scale gold mining. Sci Total Environ 267, 151-168.
30. Drasch G et al. (2002) Scientific comment on the German human biological monitoring values (HBM values) for mercury. Int. J Environ Health 205, 509-512.
31. Egglestone DW et al. (1987) Correlation of dental amalgam with mercury in brain tissue. J Prosthet Dent 58, 704-707.
32. Eggleston DW et al. (1987), Correlation of dental amalgam with mercury in brain tissue, Research and Education, 58 (6), 704 – 707.
33. Eggleston DW et al. (1987) Correlation of dental amalgam with mercury in 34. Frank I et al. (2000) Immuntoxikologie chronischer Quecksilberbelastung, Zeitsch Umweltmed, 8 (2), 94 – 100.
35. Godfrey ME et al. (2003) Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. Journal of Alzheimerûs Discease, 5, 189 – 195.
36. Gundlach P (1979) Neurologische Aspekte der Quecksilbervergiftung eine Literarische Übersicht, Inaugural-Dissertation München 1979.
37. Hahn LJ et al. 1990 Dental „silver“ tooth fillings: a source of mercury exposure revealed by whole-body image scan tissue analysis. FASEB.J 3, 2641-2646.
38. Hahn LJ et al. 1990 Dental „silver“ tooth fillings: a source of mercury exposure revealed by whole-body image scan tissue analysis. FASEB.J 3, 2641-2646.
39. Hassan AN et al. (1999) Humoral Assessment of Neurotoxicity and Auto Mechanisms, Environ Health Persp, 107 (5), 1 – 26.
40. Hoeper M (2003) Signaling Molecules in Pulmonary Hypertension, N Engl J 41. Holmes AS (2006) Chelation of Mercury for the Treatment of Autism, 42. Kalveram KJ et al. (1973) Misleading patch test results with aluminum Finn chambers an mercury salts, Contact Dermatitis. 1973: 219 – 221.
43. Kantarjian AD (??) A Syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism, 639 – 644 44. Klein CL et al. (1994) The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions, Journal of meterails science: Materials in Medicine, 5, 798 – 807.
45. Klein CL et al. (1995) Comparative studies on cytotoxic effects of dental amalgams an alternative alloys according to ISO standards in vitro, Journal of Materials Science: Materials in Medicine, 6, 708 – 714.
46. Lammers HJ (2003) Autismus durch Quecksilberbelatung? Zeitschrift für 47. Leistevuo J et al. (2001) Dental Amalgam Fillings and the Amount of organic Mercury in Human Salivia. Caries Res 35, 163-166.
48. Lorscheider FL et al. (1991) Mercury exposure from „silver“ fillings. Lancet 49. Lorscheider FL et al. (1995) Mercury exposure from „silver“ tooth fillings: emerging evidence questions a traditional dental Paradigm. FASEB J 9, 504-508.
50. Marquard H, Schäfer SG (1997) Lehrbuch der Toxikologie, Spektrum Akademischer Verlag, Heidelberg, Berlin, p. 530.
51. Mauch E et al. (1995) Trace metals in multiple sclerosis, Neurology. Psychiatry and Brain Research, 149 – 154.
52. Miura K et al. (1995) Mercury Toxicity in Goyer RA et al. Toxicology of metals. Springer, Berlin, Heidelberg, New York, London, 163-187.
53. Müller KE (2002) BfArM verfolgt Strategien der Vergangenheit. Zeitsch f 54. Müller KE et al. (1997) Szintigraphie der dopaminergen D2-Rezeptoren bei Belastung durch Xenobiotika, Ökol. Ärztebl. 1, 28-31.
55. Müller KE (2003) Zwei Episonden eines Guillain-Barré-Syndrom (GBS) nach Roxithromycin und Mercurius solubilis, umg, 16 (2), 101 – 102.
56. Müller KE (2004) Immuntoxikologie der Metalle, umg, 17 (4), 299 – 301.
57. Muss C et al. (2000) Untersuchungen zur immunsuppressiven Wirkung von Dentallegierungen unter Verwendung von Recall-Antigenen – eine Praxisstudie, Zeitsch Umweltmed, 4, 228 – 233.
58. Mutter J et al. (2004) Amalgam studies: disregarding basic principels of mercury toxicity. Int J Hyg Environ Health 207, 391-397.
59. Mutter J et al. (2004) Alzheimer Disease: Mercury as pathogenetic factor an apolipoprotein E as a moderator, Neuroendocrinol Lett 2004, 331 – 339.
60. Mutter J et al. (2006) Quecksilber und Autismus: Zunehmende Beweise? Umwelt-medizin-gesellschaft 1/2006, 53 – 60.
61. Mutter J et al. (2004) Alzheimer Disease: Mercury as pathogenetic factor an apolipoprotein E as a moderator, Neuroendocrinol Lett 2004: 275 – 283.
62. Nylander M (1986) Mercury in pituitary glands of dentists. Lancet 1, 442.
63. Pelletier L et al. (1995) Immunotoxicology of Metals in Goyer RA et al. Toxicology of Metals, Springer, Berlin, Heidelberg, New York, London, p 77 –87.
64. Pizzichini M et al. (2002) Release of mercury from dental amalgam and its nfluence on salivary antioxidant activity. Sci Total Environ 284, 19-25.
65. Powell JJ et al. (1999) Evidence for the role of Encironmental Agents in the Initiation or Progression of Autoimmune Conditions, Environ Health Perspect, 107 (S5), 667 – 670.
66. Reichel F.X. et all (2007) Taschenatlas der Pharmakologie und Toxikologie für Zahnmedizin, Georg-Thieme-Verlag, Stuttgart 67. Rowley B et al. (2004) Mechanisms of heavy metal-induced autoimmunity, Molecular Immunology, 42, 833 – 838.
68. Siblerud RL et al. (1994) Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis, The Science of the Total Environment 142, 191 – 205.
69. Siblerud RL et al. (1992) A Comparison of mental Health of mulitple sclerosis patients with silver/mercury dental fillings an those with fillings removed, Psychological reports, 1139 – 1151.
70. Stejskal J et al. (1999) The role of metals in autoimmunity an the link to neuroendocrinology, Neuroendocrinol Letters, 20, 351 – 364.
71. Stejskal V et al. (1995) Mercury-Specific Lymphocytes: An Indication of Mercury Allergy in Man, J Clin Immun, 16 (1),31 – 40.
72. Sterzl I et al. (1999) Mercury and nickel allergy: risk factors in fatigue an autoimmunity, Neuroendocrinol Letters, 20, 221 – 228.
73. Stewart WF et al. (2002) ApoE Genotype, Past Adult lead exposure, and Neurobehavioral Function, Enviromental Health Perspectives Volume 110, 501 – 505.
74. Uversky V et al. (2004) Metal-triggered Structural Transformations, Aggregation, an Fibrillation of Human Synuclein, J Biol Chem, 276 (47),1 –28.
75. Valentine-Thon E et al. (2005) Metallsensibilisierung: Nachweis, Validierung und Verlaufskontrolle mittels Lymphozytentransformations-Test (LTT-MELISA), Zs.f. Orthomol.Med., 1, 12 – 15.
76. Valentine-Thon et al. (2003) Validity of MELISA for metal sensitivity testing, Neuroendocrinol Letters, 24, 57 – 64.
77. Vimy M et al. (1990) Maternal-fetal distribution of mercury (203Hg) released fro dental amalgam fillings. Am J Physiol 258, R939-945.
78. Warfvinge K et al. (2006) Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol 132 (2), 299-309. 79. Weiner JA et al. (1993) The relationship between mercury concentration in human organs and different predictor variables. Sci Total Environ 138, 101-115.
80. WHO (1990) Environmental Health Criteria 118: Inorganic Mercury. World 81. WHO/OMS. Inorganic mercury. Environmental Health Criteria 118, IPCS 82. Wojcik DP et al. (2006) Mercury toxicity presenting as chronic fatigue, memory impairment an depression, Neuroendocrinol Lett 2006, 415 – 423.
83. Yamane Y (1977) Suppressive effect of zinc on the toxicity of mercury. Chem 84. Yannai S et al. (1991) Transformationn of Inorganic Mercury by Candida albicans and Saccharomyces cerevisiae. Appl Environm Mocrobiol 57:1, 245-247.
85. Yoshida M (2002), Placental to Fetal Transfer of Mercury and Fetotoxicity, 86. Ziemba SE et al. (2005) Inorganic Mercury Inhibits the Activation of LAT in T- Cell Receptor-Mediated Signal Transduction, Toxicological Sciences, 89 (1), 145 – 153.

Source: http://europaem.de/politics/references.pdf

hamsnetwork.org

HAMS Position Statement on Psychiatric Medications 1) HAMS recognizes that psychiatric medications can be great lifesavers for many people and we encourage people who are benefitting from psychiatric medications to continue taking them; we also encourage people who may benefit from them to consult with their doctor about giving them a try. 2) HAMS also recognizes that psychiatric medicati

hamsnetwork.org

HAMS Position Statement on Psychiatric Medications 1) HAMS recognizes that psychiatric medications can be great lifesavers for many people and we encourage people who are benefitting from psychiatric medications to continue taking them; we also encourage people who may benefit from them to consult with their doctor about giving them a try. 2) HAMS also recognizes that psychiatric medicati

© 2010-2014 Pdf Medical Search